The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome and other diseases and conditions that are mediated by excessive glucocorticoid action.

 
Web www.patentalert.com

< Piperidine-piperazine ligands for neurotransmitter receptors

> Indazolone derivatives useful as 11b-HSD1 inhibitors

> 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes

~ 00508